Can metabolomics in addition to genomics add to prognostic and predictive information in breast cancer?
<p>Abstract</p> <p>Genomic data from breast cancers provide additional prognostic and predictive information that is beginning to be used for patient management. The question arises whether additional information derived from other 'omic' approaches such as metabolomics c...
Main Author: | Howell Anthony |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-11-01
|
Series: | BMC Medicine |
Online Access: | http://www.biomedcentral.com/1741-7015/8/73 |
Similar Items
-
Immunophenotyping in myelodysplastic syndromes can add prognostic information to well-established and new clinical scores.
by: Suiellen C Reis-Alves, et al.
Published: (2013-01-01) -
Stromal genes add prognostic information to proliferation and histoclinical markers: a basis for the next generation of breast cancer gene signatures.
by: Dwain Mefford, et al.
Published: (2012-01-01) -
Identification and characterization of prognostic factors in breast cancer using MR metabolomics
by: Giskeødegård, Guro Fanneløb
Published: (2011) -
Can Doppler or contrast-enhanced ultrasound analysis add diagnostically important information about the nature of breast lesions?
by: Daniela Stanzani, et al. -
Can diffusion-weighted imaging add information in the evaluation of breast lesions considered suspicious on magnetic resonance imaging?
by: Camila Souza Guatelli, et al.